Companies: 10,795·Total market cap: $144.5T
Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.

LXRXNASDAQHealthcare● Active
$1.88
$-0.03(-1.57%)
Market Cap$835088480
P/E Ratio
52W High$2.53
52W Low$0.64
Overview

Lexicon Pharmaceuticals, Inc.(LXRX)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

lxrx · 股价预测 · 14 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 14 位华尔街分析师

SellBuy

Hold

14 位分析师

共识

评级分布

Strong Buy
0
Buy
5
Hold
7
Sell
2
Strong Sell
0
合计: 14 · 买入占比: 35.7%

12 个月目标价

High

$6.00

Consensus

$6.00

+219.1% upside

Low

$6.00

Median: $6 · Last Close: $1.88

Lexicon Pharmaceuticals, Inc.(LXRX)的分析师共识为 Hold,基于过去 3 个月内 14 位华尔街分析师的评级。LXRX 的 12 个月平均目标价为 $6.00,相对当前价 $1.88 代表 +219.1% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$1.795.00%

1-day model range: $1.77–$1.81. Peak: $1.81 (-5.00%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$4+120.0%
2028$7+265.2%
2029$9+397.8%
2030$11+497.1%
2031+562.7%
Confidence:MediumCapped at 120% annual limit

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%7%50%
6Buy
1Neutral
7Sell
RSI (14)35.2Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · LXRX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$1.89SELL
MA 10$2.01SELL
MA 20$2.14SELL
MA 50$1.87BUY
MA 100$1.68BUY
MA 200$1.49BUY
Current $LXRX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$1.92SELL
EMA 10$1.98SELL
EMA 20$2.00SELL
EMA 50$1.90SELL
EMA 100$1.73BUY
EMA 200$1.49BUY
Current $LXRX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Citigroup2026-05-11
Maintains
BuyBuy
HC Wainwright & Co.2026-03-23
Maintains
BuyBuy
Citigroup2026-03-10
Maintains
BuyBuy
HC Wainwright & Co.2026-03-05
Maintains
BuyBuy
HC Wainwright & Co.2025-09-02
Maintains
BuyBuy
Citigroup2025-08-07
Maintains
BuyBuy
HC Wainwright & Co.2025-06-24
Maintains
BuyBuy
HC Wainwright & Co.2025-03-28
Maintains
BuyBuy
Needham2025-03-07
Maintains
HoldHold
HC Wainwright & Co.2025-03-07
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Lexicon Pharmaceuticals, Inc. (LXRX) stock. Of the recent 80 rating actions, 5 were upgrades and 11 were downgrades. 14 analysts currently cover LXRX.

分析师推荐趋势

Buy ratings413
Hold ratings303
Sell ratings00

LXRX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$38M

↓ 49.9% YoY

Revenue Next Year

$20M

↓ 47.2% YoY

EPS This Year

$-0.16

EPS Next Year

$-0.21

↑ 30.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast LXRX EPS of $-0.16 for the current fiscal year, based on estimates from 3 analysts. The LXRX revenue forecast is $38M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

LXRX 股价预测由两类独立数据源支撑:来自 14 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。LXRX 的共识目标价为 $6.00(+219.1% 上行空间),分析师共识为 Hold。

LXRX 的短期预测(明日)为 $1.79(-5.00%)。 LXRX 对 2027 年的股价预测均值为 $4。 LXRX 对 2030 年的预测区间为 $10–$13。

Lexicon Pharmaceuticals, Inc. 在 NASDAQ 上市,代码 LXRX。LXRX 在 2027 年的整体展望偏中性/分化,在覆盖分析师中约 36% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

LXRX 预测 · 8 个问题

根据 14 位华尔街分析师,LXRX 的 12 个月平均目标价为 $6.00,最高 $6.00、最低 $6.00。若有图表,中位目标价可在上方查看。相对当前价 $1.88,隐含约 +219.1% 的上行空间。

LXRX 目标价LXRX 分析师目标价LXRX 12个月目标价目标价 LXRX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.